dalteparin has been researched along with Dehiscence, Surgical Wound in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hydroxyproline results were found nearly similar to the bursting pressure values (subcutan (p < 0." | 1.35 | Does low molecular weight heparin impair anastomotic wound healing? ( Barit Ozgun, G; Ergul, E; Kiyak, G; Korukluoglu, B; Kusdemir, A; Ozgun, YM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alalaf, SK | 1 |
| Jawad, RK | 1 |
| Muhammad, PR | 1 |
| Ali, MS | 1 |
| Al Tawil, NG | 1 |
| Ergul, E | 1 |
| Ozgun, YM | 1 |
| Kiyak, G | 1 |
| Barit Ozgun, G | 1 |
| Korukluoglu, B | 1 |
| Kusdemir, A | 1 |
| Ferres, MA | 1 |
| Olivarez, SA | 1 |
| Trinh, V | 1 |
| Davidson, C | 1 |
| Sangi-Haghpeykar, H | 1 |
| Aagaard-Tillery, KM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessing Women's Preferences for Postpartum Thromboprophylaxis: the PREFER-PostPartum[NCT05318547] | 52 participants (Anticipated) | Interventional | 2022-05-13 | Recruiting | |||
| Bemiparin Versus Enoxaparin as Thromboprophylaxis Following Vaginal and Abdominal Deliveries: A Prospective Clinical Trial[NCT01588171] | 7,020 participants (Actual) | Interventional | 2012-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dalteparin and Dehiscence, Surgical Wound
| Article | Year |
|---|---|
Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial.
Topics: Adult; Anticoagulants; Cesarean Section; Enoxaparin; Female; Hematoma; Heparin, Low-Molecular-Weight | 2015 |
Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial.
Topics: Adult; Anticoagulants; Cesarean Section; Enoxaparin; Female; Hematoma; Heparin, Low-Molecular-Weight | 2015 |
Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial.
Topics: Adult; Anticoagulants; Cesarean Section; Enoxaparin; Female; Hematoma; Heparin, Low-Molecular-Weight | 2015 |
Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial.
Topics: Adult; Anticoagulants; Cesarean Section; Enoxaparin; Female; Hematoma; Heparin, Low-Molecular-Weight | 2015 |
2 other studies available for dalteparin and Dehiscence, Surgical Wound
| Article | Year |
|---|---|
Does low molecular weight heparin impair anastomotic wound healing?
Topics: Anastomosis, Surgical; Animals; Enoxaparin; Fibrinolytic Agents; Hydroxyproline; Intestines; Rats; R | 2009 |
Rate of wound complications with enoxaparin use among women at high risk for postpartum thrombosis.
Topics: Adult; Anticoagulants; Cesarean Section; Enoxaparin; Female; Humans; Puerperal Disorders; Retrospect | 2011 |